期刊文献+

氯吡格雷联合阿司匹林对稳定型心绞痛患者凝血指标及心血管事件发生的影响

Impact of Clopidogrel Combined with Aspirin on Coagulation Indicators and Cardiovascular Events in Patients with Stable Angina
下载PDF
导出
摘要 目的探讨氯吡格雷联合阿司匹林对稳定型心绞痛患者凝血指标及心血管事件发生的影响。方法将90例稳定性心绞痛患者随机分为对照组(n=45)和观察组(n=45),对照组口服阿司匹林肠溶片,观察组在对照组基础上采用氯吡格雷治疗。比较两组的临床疗效、凝血指标、心血管事件发生率。结果观察组治疗总有效率为91.1%,明显高于对照组的75.6%(P<0.05)。治疗后,观察组APTT、PT长于对照组,PAR低于对照组(P<0.05)。观察组治疗后6个月的心血管事件发生率为4.4%,低于对照组的17.8%(P<0.05)。结论氯吡格雷联合阿司匹林治疗稳定型心绞痛患者可减少心绞痛发作次数和频率,改善凝血指标,降低心血管事件发生率。 Objective To explore the impact of clopidogrel combined with aspirin on coagulation indicators and cardiovascular events in patients with stable angina.Methods 90 patients with stable angina were randomly divided into control group(n=45)and observation group(n=45).The control group was given oral aspirin enteric coated tablets,while the observation group was treated with clopidogrel on the basis of the control group.The clinical efficacy,coagulation indicators,and incidence of cardiovascular events were compared between the two groups.Results The total effective rate of treatment in the observation group was 91.1%,significantly higher than 75.6%in the control group(P<0.05).After treatment,the APTT and PT of the observation group were longer than those of the control group,and the PAR was lower than that of the control group(P<0.05).The incidence of cardiovascular events in the observation group after 6 months of treatment was 4.4%,lower than 17.8%in the control group(P<0.05).Conclusions Clopidogrel combined with aspirin in the treatment of patients with stable angina can reduce the times and frequency of angina attacks,improve the coagulation indicators,and reduce the incidence of cardiovascular events.
作者 罗文婷 张彪 黄浩 LUO Wenting;ZHANG Biao;HUANG Hao(Department of Pharmacy,Pingdingshan First People's Hospital,Pingdingshan 467000,China)
出处 《临床医学工程》 2024年第5期601-602,共2页 Clinical Medicine & Engineering
关键词 氯吡格雷 阿司匹林 稳定型心绞痛 凝血指标 心血管事件 Clopidogrel Aspirin Stable angina Coagulation indicator Cardiovascular event
  • 相关文献

参考文献7

二级参考文献99

  • 1无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2053
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 3Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 4Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 5Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 6Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 7O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 8Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 9Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 10Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.

共引文献2162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部